title: Renal impairment with sitagliptin: is there a need for active monitoring of potential renal toxicity?
authors.affiliation: Diabeticare Unit, Hillingdon Hospital, Uxbridge, Middlesex UB8 3HX.
authors.forename: J M
authors.initials: JM
authors.lastname: Lestner
authors.forename: R
authors.initials: R
authors.lastname: Baburaj
authors.forename: C M B
authors.initials: CM
authors.lastname: Edwards
mesh_terms: D000368:Aged; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D011719:Pyrazines / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced* / Q000628:therapy*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate